Startseite>>Signaling Pathways>> Cell Cycle/Checkpoint>> Proteolysis>>Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt)

Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt) (Synonyms: Caspase-1 Fluorogenic Substrate V, Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH, Mca-YVADAP-Lys(Dnp)-OH, (7-Methoxycoumarin-4-yl)acetyl-YVADAPK(2,4-dinitrophenyl)-OH)

Katalog-Nr.GC47607

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt) Chemische Struktur

Cas No.: N/A

Größe Preis Lagerbestand Menge
500 μg
214,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Mca-YVADAP-K(Dnp)-OH is a substrate for caspase-1 and angiotensin-converting enzyme 2 (ACE2).1,2 Upon cleavage by caspase-1 or ACE2, 7-methoxycoumarin-4-acetyl (Mca) is released and its fluorescence can be used to quantify enzyme activity. Mca displays excitation/emission maxima of 328/420 nm, respectively.

1.Vickers, C., Hales, P., Kaushik, V., et al.Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidaseJ. Biol. Chem.277(17)14838-14843(2002) 2.Enari, M., Talanian, R.V., Wong, W.W., et al.Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosisNature380(6576)723-726(1996)

Bewertungen

Review for Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mca-YVADAP-K(Dnp)-OH (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.